NCT00016263View on ClinicalTrials.gov

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2000

Study Completion Date

December 31, 2004

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

oblimersen sodium

DRUG

dacarbazine

Trial Locations (2)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

07922

Genta Incorporated, Berkeley Heights

Sponsors

Lead Sponsor

Genta Incorporated
All Listed Sponsors
lead

Genta Incorporated

INDUSTRY